Dr. J.F. Rodriguez Moreno obtained his Degree in Medicine and Surgery in 2006 from the University of Murcia, Spain, and his PhD in 2016 from the Complutense University of Madrid (Cum Laude and Extraordinary Doctorate Award). He trained in Medical Oncology at the Hospital Universitario Clinico San Carlos in Madrid, Spain and undertake a fellowship in GU tumors & Melanoma at the Peter McCallum Cancer Center, Melbourne, Australia.

Since 2011, he has been working as a Medical Oncologist and Coordinator of the Prostate Cancer and Melanoma Programs at HM CIOCC. He has participated in more than 200 Phase I, II, and III clinical trials, and leads a translational research line focused on Prostate Cancer and PARP inhibitors.

Dr. Rodriguez Moreno has co-authored over 40 peer reviewed scientific articles, in addition to different chapters in oncology books, as well as several hundreds of presentations at different major conferences and meetings.

He is also a member of the Board of Directors of the Spanish Group for Transversal Oncology and Rare and Infrequent Tumors; and actively collaborates with various working groups of major national and international oncology societies.

Dr. Rodriguez Moreno is strongly committed to clinical research, leading numerous clinical trials to advance oncology and improve patient care.